Nexxen to Announce Second Quarter 2025 Financial Results on August 13, 2025 GlobeNewswire July 30, 2025 NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, will release its financial results for the three […]
Humanoid Global Appoints Dr. Yue Hu to Humanoid Technical Advisory Committee – NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – GlobeNewswire July 30, 2025 Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused
NextGen Digital Platforms Announces Plans to Expand AI Strategy through Integration with Bittensor Network GlobeNewswire July 30, 2025 Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) — NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company“) is pleased to announce its planned strategic integration with the Bittensor (TAO) ecosystem, a decentralized network designed for
Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire July 30, 2025 WVE-006, the leading GalNAc-RNA editing oligonucleotide designed to correct AAT protein and address both lung and liver manifestations of AATD, rapidly advancing in RestorAATion-2 study of AATD patients; multi-dosing is complete in first cohort (200 mg) and single
Watsco Reports Second Quarter 2025 Results and Provides Update on Innovation & Strategic Technology Initiatives GlobeNewswire July 30, 2025 Record Gross Profit Margins & Expanded Operating Margins Amidst A2L Product Transition; Strong Balance Sheet Fortifies the Company and Enables Continued Investments in Growth MIAMI, July 30, 2025 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced
TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update Conference Call to be Held Monday, August 4, 2025, at 8:30 am ET GlobeNewswire July 30, 2025 NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday,
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products GlobeNewswire July 30, 2025 DURHAM, N.C., July 30, 2025 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced today a significant milestone with the U.S. Food and Drug Administration (FDA) 510(k) clearances for both TalisMann(TM) and
Amerigo Announces Q2-2025 Results & Quarterly Dividend GlobeNewswire July 30, 2025 Q2-2025 Net Income of $7.5 million Robust EBITDA1 of $17.8 million and Free Cash Flow to Equity1 of $6.5 million 16th Consecutive Quarterly Dividend of Cdn$0.03 Declared $7.6 million Returned through Dividends and Share Buybacks in Q2-2025 VANCOUVER, British Columbia, July 30, 2025 (GLOBE
PetVivo Holdings Inc. to Trade on OTCQX Best Market GlobeNewswire July 30, 2025 MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX PETV; OTCID: PETVW) working in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively “PetVivo” or the “Company”), an emerging biomedical device company focused on the commercialization of innovative medical
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025 GlobeNewswire July 30, 2025 BOSTON, July 30, 2025 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced